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The largest magnitude of Σ and σ for H&N was 1.94 mm, SNC 
was 1.56 mm, breast was 1.87 mm, thorax was 3.33 mm, 
pelvis was 3.75 mm and prostate was 2.89 mm. The PTV 
margins required are <4.5 mm for brain and H&N lesions, 
<5.5 mm for breast cancers, but range from 4.5 to 9 mm for 
thorax, prostate and pelvis lesions. 
Theses values indicate the setup variations of each patient. 
The variations were smaller for the breast, SNC and H&N 
cohorts than the prostate, pelvis and thorax cohorts. The 
pelvis and breast cohorts showed the greatest variation in 
lateral direction and the prostate cohorts in vertical 
direction. The largest variation were presented in thorax 
cohorts in longitudinal direction and the lowest were in the 
SNC cohorts. 
 
Conclusion: As the setup errors vary according to each 
immobilization systems, the analysis of each institution`s 
specific setup errors is essential for determining the PTV 
margins. The results were also used to define action level for 
online correction. 
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Purpose or Objective: The purpose of this project is to 
gather knowledge on the movement of pelvic lymph nodes 
relative to the prostate, seminal vesicles and bones in the 
pelvis and how this may affect the patient treatment plan.  
 
Material and Methods: Until present, 10 patients have been 
included in the study. All patients have diagnosed prostate 
cancer and were treated with radiation therapy with curative 
intent. The patients followed the normal preparation and 
treatment procedure at our clinic - however, six additional 
MRI scans were acquired (baseline: before RT, on treatment 
day 1, 3, 5, 20 and 35) see figure. In each image set, several 
structures were delineated including fiducial markers, bony 
structures and lymph nodes. A radiologist identified lymph 
nodes along the common spread paths of prostate cancer. No 
suspected pathological nodes were found. Oncentra (Elekta) 
was used for image registration. Baseline images were 
defined as reference images and all other examinations were 
registered to the reference in two separate ways; bone 
matching and fiducial markers matching. For the bone 
matching, four structures were outlined; the disc between 
S1-S2, head of the right and left femur and the pubic 
symphysis. For the fiducial marker matching, the three gold 
markers in the prostate were outlined. In both cases the 
images were manually matched. Lymph node, seminal vesicle 
and prostate movements and morphological change were 
evaluated In MATLAB. Lymph nodes were grouped into 
regions: para-aortic (PA), common iliac (CI), pre-sacral (PS), 
internal iliac (II), obturator (Obt), and external iliac (EI) 
lymph nodes. 
 
 
 
Results: We found that prostate moves up to 10 mm in 
anterior-posterior direction and up to 5 mm in right-left and 
cranio-caudal directions relative to bony anatomy from 
baseline scan. The lymph node group with the largest 
movements in right-left direction were CI with up to 20 mm 
difference from baseline. In the anterior-posterior and 
cranio-caudal directions, the maximum movement was 9 mm 
relative to bone from baseline scan. For the lymph nodes in 
the EI and PS regions, a significant difference was found 
depending on whether bone or fiducial markers were used for 
registration in right-left or cranio-caudal directions. In the 
other cases, no statistically significant difference between 
bone matching and fiducial marker matching was found 
 
Conclusion: Preliminary findings suggest that the pelvic 
lymph nodes are more mobile than expected, indicating the 
need to account for that in treatment planning. However, 
more patients need to be included in the study before a 
conclusion can be drawn on the implications on the 
treatment plan. 
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Purpose or Objective: Optical 3D Surface Scanner (3D-OSS) is 
a simple and easily reproducible method for patient 
alignment, and is an accurate tool to show anatomical 
changes, for example, in breast locations. The aim of this 
study was to evaluate the feasibility of both achieving within 
a few minutes an 3D-OSS using a smartphone and creating an 
image fusion between this 3D-OSS and the CT scanner, in a 
simple, cheap and reliable way. 
 
Material and Methods: A smartphone and a free commercial 
app (TRNIO, www.trnio.com) were used to create an 3D-OSS. 
This app takes a series of pictures of your object as you move 
your smartphone around it. After a scan is completed, a 3D 
model will be generated on your phone. This 3D map is 
available for downloading on the TRNIO website. Although 
there are several image reconstructing algorithms available, 
in order to first show the feasibility of the method described 
here we will be using the commercial app. In the meantime, 
